Trials / Completed
CompletedNCT02754479
A Clinical Evaluation of the Treatment of Spider Veins on the Ankles
A Clinical Evaluation of the Treatment of Spider Veins on the Ankles Using a Dual Wavelength Laser Emitting 532 nm and 1064 nm Laser Energy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Cutera Inc. · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and effectiveness of the Excel V system for the treatment of lower extremity spider veins on the ankles.
Detailed description
The purpose of this study is to evaluate the real-world effectiveness of the 532 nm and 1064 nm Nd:YAG lasers within the Cutera Excel V system for the treatment of lower extremity spider veins, specifically on the ankles, within a clinic setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nd:YAG laser | Treatment of lower extremity spider veins |
Timeline
- Start date
- 2016-06-10
- Primary completion
- 2016-12-22
- Completion
- 2017-03-15
- First posted
- 2016-04-28
- Last updated
- 2023-05-09
- Results posted
- 2023-05-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02754479. Inclusion in this directory is not an endorsement.